Cwm, LLC Allovir, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Allovir, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,004 shares of ALVR stock, worth $552. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,004

Previous 2,275 55.87%

Holding current value

$552

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$0.7 - $0.82 $889 - $1,042	-1,271 Reduced 55.87%	1,004 $1,000
Q2 2024 Jul 09, 2024	BUY	$0.72 - $0.82 $506 - $577	704 Added 44.81%	2,275 $2,000
Q1 2024 Apr 05, 2024	BUY	$0.64 - $0.78 $1,002 - $1,221	1,566 Added 31320.0%	1,571 $1,000
Q4 2023 Feb 01, 2024	SELL	$0.68 - $2.39 $610 - $2,146	-898 Reduced 99.45%	5 $0
Q3 2023 Oct 11, 2023	BUY	$2.15 - $3.64 $131 - $222	61 Added 7.24%	903 $2,000
Q2 2023 Aug 03, 2023	BUY	$3.17 - $5.82 $82 - $151	26 Added 3.19%	842 $3,000
Q4 2022 Feb 01, 2023	SELL	$4.7 - $9.98 $32 - $69	-7 Reduced 0.85%	816 $4,000
Q2 2022 Jul 28, 2022	SELL	$3.26 - $7.06 $35 - $77	-11 Reduced 1.32%	823 $3,000
Q1 2022 Apr 21, 2022	SELL	$6.75 - $13.52 $675 - $1,352	-100 Reduced 10.71%	834 $6,000
Q4 2021 Jan 31, 2022	SELL	$12.94 - $25.99 $1.44 Million - $2.9 Million	-111,544 Reduced 99.17%	934 $12,000
Q1 2021 Sep 15, 2021	BUY	$20.81 - $45.5 $97,432 - $213,031	4,682 Added 4.34%	112,478 $2.22 Million
Q1 2021 Apr 27, 2021	SELL	$20.81 - $45.5 $97,432 - $213,031	-4,682 Reduced 4.16%	107,796 $2.52 Million
Q4 2020 Sep 15, 2021	BUY	$23.94 - $46.81 $170,333 - $333,053	7,115 Added 6.75%	112,478 $2.22 Million
Q4 2020 Jan 27, 2021	SELL	$23.94 - $46.81 $170,333 - $333,053	-7,115 Reduced 6.33%	105,363 $4.05 Million
Q3 2020 Sep 15, 2021	BUY	$21.05 - $42.7 $273,081 - $553,947	12,973 Added 13.04%	112,478 $2.22 Million
Q3 2020 Oct 19, 2020	SELL	$21.05 - $42.7 $273,081 - $553,947	-12,973 Reduced 11.53%	99,505 $2.74 Million
Q2 2020 Sep 15, 2021	BUY	N/A	112,478 New	112,478 $2.22 Million
Q2 2020 Jul 22, 2020	SELL	N/A	-112,478 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	N/A	112,478 New	112,478 $2.22 Million
Q1 2020 Apr 28, 2020	SELL	N/A	-112,478 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	N/A	112,478 New	112,478 $2.22 Million
Q4 2019 Jan 27, 2020	SELL	N/A	-112,478 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	N/A	112,478 New	112,478 $2.22 Million
Q3 2019 Oct 22, 2019	SELL	N/A	-112,478 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	N/A	112,478 New	112,478 $2.22 Million
Q2 2019 Jul 31, 2019	SELL	N/A	-112,478 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	N/A	112,478 New	112,478 $0

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $51.2M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account